Data / Form D filings / Microbiome Insights Inc.
Microbiome Insights Inc.: Form D filings
Microbiome Insights Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC between 2015 and 2019. The latest, on March 27, 2019, reports $115,978 sold of a $388,864 offering to 4 investors.
Find out what Microbiome Insights Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 595 BURRARD STREET, SUITE 2600, Vancouver, British Columbia, Canada, V7X 1
- Phone
- (604) 356-4228
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1657948
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2019 | New notice | $388,864 | $115,978 | $272,886 | 4 | Jan 25, 2019 | sec.gov |
| Aug 16, 2017 | New notice | $167,813 | $167,813 | $0 | 4 | Aug 1, 2017 | sec.gov |
| Nov 10, 2015 | New notice | $18,927 | $18,927 | $0 | 1 | Sep 23, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| WILLIAM WHEELER MOHN | Executive Officer, Director | |
| MALCOLM COOPER KENDALL | Executive Officer, Director | |
| MICHAEL R. FANNON | Director | |
| BRADLEY COOPER POPOVICH | Director | |
| PIETER COOPER CULLIS | Director | |
| BARTON BRETT FINLAY | Executive Officer, Director |
Every Form D from the week of Mar 25, 2019 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Microbiome Insights Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.